Physician profile
Thomas Childress
NPI 1013094978
$283,198.25
in general payments reported to CMS, 2019-2025
31 companies · $758 in 2025
The $758 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $277K · 2021: $851 · 2022: $587 · 2023: $2,879 · 2024: $800 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,292 · Travel and Lodging: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,291.81 |
| Travel and Lodging | $1,145.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $274,989.00 | 2020 | |
| Fusion Orthopedics USA, LLC | $1,256.56 | 2023-2025 | |
| Stryker Corporation | $1,149.79 | 2021-2025 | Variax, Prophecy, Inbone |
| Smith+Nephew, INC. | $1,052.39 | 2020-2024 | Stravix, Oasis, Grafix Pl |
| Integra Lifesciences Corporation | $715.43 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Alpha Orthopedic Systems | $640.21 | 2020-2022 | |
| Misonix INC | $446.61 | 2020-2021 | |
| Bioventus LLC | $351.19 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Baxter Healthcare | $246.10 | 2019 | |
| Kerecis Limited | $184.32 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Nevro Corp. | $183.87 | 2023 | Senza |
| Linvatec Corporation | $173.66 | 2023 | Allograft Tissue, Fracture and Correction Colag 2, Biobrace 23mm |
| Inari Medical, INC. | $168.16 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Wright Medical Technology, INC. | $149.65 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $144.09 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $140.75 | 2019-2021 | |
| Medline Industries Lp | $132.76 | 2020 | |
| Djo, LLC | $127.59 | 2023 | Aircast, Donjoy |
| Organogenesis INC. | $124.74 | 2022 | |
| Paratek Pharmaceuticals, INC. | $114.48 | 2023 | Nuzyra |
| Depuy Synthes Sales INC. | $108.85 | 2022-2023 | Na, Hammerlock |
| Tactile Systems Technology INC | $107.94 | 2019 | |
| Medshape, INC. | $106.94 | 2023 | Dynanail, Dynanail Hybrid, Dynanail Helix, Washer, 15 Mm |
| Avita Medical Americas, LLC | $89.65 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Depuy Synthes Products, INC. | $89.47 | 2020 | |
| Acumed LLC | $52.47 | 2023 | Acumed |
| Zimmer Biomet Holdings, INC. | $38.55 | 2019 | |
| Orthofix Medical, INC. | $32.48 | 2024 | Ankle Hindfoot Nailing System, Truelok |
| Life Spine, INC. | $31.57 | 2020 | |
| Grt US Holding, INC. | $30.86 | 2020 | |
| Arteriocyte Medical Systems, INC. | $18.12 | 2025 | Magellan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$925,011.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Childress listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.